BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

877 related articles for article (PubMed ID: 27151771)

  • 1. Voltage-gated calcium channels are abnormal in cultured spinal motoneurons in the G93A-SOD1 transgenic mouse model of ALS.
    Chang Q; Martin LJ
    Neurobiol Dis; 2016 Sep; 93():78-95. PubMed ID: 27151771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycine receptor channels in spinal motoneurons are abnormal in a transgenic mouse model of amyotrophic lateral sclerosis.
    Chang Q; Martin LJ
    J Neurosci; 2011 Feb; 31(8):2815-27. PubMed ID: 21414903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early deficits in GABA inhibition parallels an increase in L-type Ca
    Venugopal S; Ghulam-Jhelani Z; Ahn IS; Yang X; Wiedau M; Simmons D; Chandler SH
    Neurobiol Dis; 2023 Feb; 177():105992. PubMed ID: 36623607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
    Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
    Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered development in GABA co-release shapes glycinergic synaptic currents in cultured spinal slices of the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Medelin M; Rancic V; Cellot G; Laishram J; Veeraraghavan P; Rossi C; Muzio L; Sivilotti L; Ballerini L
    J Physiol; 2016 Jul; 594(13):3827-40. PubMed ID: 27098371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The vulnerability of spinal motoneurons and soma size plasticity in a mouse model of amyotrophic lateral sclerosis.
    Dukkipati SS; Garrett TL; Elbasiouny SM
    J Physiol; 2018 May; 596(9):1723-1745. PubMed ID: 29502344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interfering with lysophosphatidic acid receptor edg2/lpa
    Gento-Caro Á; Vilches-Herrando E; García-Morales V; Portillo F; Rodríguez-Bey G; González-Forero D; Moreno-López B
    Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1004-1018. PubMed ID: 33508894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium dysregulation, mitochondrial pathology and protein aggregation in a culture model of amyotrophic lateral sclerosis: mechanistic relationship and differential sensitivity to intervention.
    Tradewell ML; Cooper LA; Minotti S; Durham HD
    Neurobiol Dis; 2011 Jun; 42(3):265-75. PubMed ID: 21296666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.
    Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C
    Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential involvement of vesicular and glial glutamate transporters around spinal α-motoneurons in the pathogenesis of SOD1
    Ohgomori T; Yamasaki R; Takeuchi H; Kadomatsu K; Kira JI; Jinno S
    Neuroscience; 2017 Jul; 356():114-124. PubMed ID: 28526579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential potentiation of AMPA-mediated currents in brainstem hypoglossal motoneurons by subchronic exposure of mice expressing the human superoxide dismutase 1 G93A gene mutation to neurotoxicant methylmercury in vivo.
    Yuan Y; Bailey JM; Rivera-Lopez GM; Atchison WD
    Neurotoxicology; 2024 Jan; 100():72-84. PubMed ID: 38065418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early excitability changes in lumbar motoneurons of transgenic SOD1G85R and SOD1G(93A-Low) mice.
    Pambo-Pambo A; Durand J; Gueritaud JP
    J Neurophysiol; 2009 Dec; 102(6):3627-42. PubMed ID: 19828728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of mutated SOD1 gene in synaptic stripping and MHC class I expression following nerve axotomy in ALS murine model.
    Kassa RM; Bonafede R; Boschi F; Malatesta M; Mariotti R
    Eur J Histochem; 2018 May; 62(2):2904. PubMed ID: 29943955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperexcitability of cultured spinal motoneurons from presymptomatic ALS mice.
    Kuo JJ; Schonewille M; Siddique T; Schults AN; Fu R; Bär PR; Anelli R; Heckman CJ; Kroese AB
    J Neurophysiol; 2004 Jan; 91(1):571-5. PubMed ID: 14523070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-expression of N-type calcium channels in cortical neurons from a mouse model of Amyotrophic Lateral Sclerosis.
    Pieri M; Caioli S; Canu N; Mercuri NB; Guatteo E; Zona C
    Exp Neurol; 2013 Sep; 247():349-58. PubMed ID: 23142186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
    Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
    Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
    Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early signs of motoneuron vulnerability in a disease model system: Characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice.
    Avossa D; Grandolfo M; Mazzarol F; Zatta M; Ballerini L
    Neuroscience; 2006; 138(4):1179-94. PubMed ID: 16442737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1
    Bonifacino T; Provenzano F; Gallia E; Ravera S; Torazza C; Bossi S; Ferrando S; Puliti A; Van Den Bosch L; Bonanno G; Milanese M
    Neurobiol Dis; 2019 Sep; 129():79-92. PubMed ID: 31102766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.